HCW Biologics Inc. logo

HCW Biologics Inc.

NASDAQ:HCWB

Overview | Financials
Company Name HCW Biologics Inc.
Symbol HCWB
Currency USD
Price 0.342
Market Cap 12,950,732
Dividend Yield 0%
52-week-range 0.276 - 2.52
Industry Biotechnology
Sector Healthcare
CEO Dr. Hing C. Wong Ph.D.
Website https://www.hcwbiologics.com

An error occurred while fetching data.

About HCW Biologics Inc.

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302

Related Stocks

Anebulo Pharmaceuticals, Inc. logo

Anebulo Pharmaceuticals, Inc.

ANEB

1.596 USD

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

UTRS

0 USD

TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc.

TCRX

2.63 USD

Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

GALT

1.15 USD

Eyenovia, Inc. logo

Eyenovia, Inc.

EYEN

0.086 USD

Centogene N.V. logo

Centogene N.V.

CNTG

0.325 USD

Augmedix, Inc. logo

Augmedix, Inc.

AUGX

2.345 USD

Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc.

VIRX

0.17 USD

Financials

Numbers are in millions USD

Numbers are in millions USD